View in EDS

Are lazertinib and osimertinib comparable for treating advanced EGFR-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA study.

Saved in:
Bibliographic Details
Title: Are lazertinib and osimertinib comparable for treating advanced EGFR-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA study.
Authors: Urbanska EM; Department of Oncology, Center for Cancer and Organ Diseases, Righospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Santoni-Rugiu E; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, University of Copenhagen UCPH, Copenhagen, Denmark., Grauslund M; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Sørensen JB; Department of Oncology, Center for Cancer and Organ Diseases, Righospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, University of Copenhagen UCPH, Copenhagen, Denmark.
Source: Journal of thoracic disease [J Thorac Dis] 2026 May 31; Vol. 18 (5), pp. 559. Date of Electronic Publication: 2026 May 27.
Publication Type: Editorial; Comment
Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42306727
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Are lazertinib and osimertinib comparable for treating advanced EGFR-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Urbanska+EM%22">Urbanska EM</searchLink>; Department of Oncology, Center for Cancer and Organ Diseases, Righospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Santoni-Rugiu+E%22">Santoni-Rugiu E</searchLink>; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, University of Copenhagen UCPH, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Grauslund+M%22">Grauslund M</searchLink>; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Sørensen+JB%22">Sørensen JB</searchLink>; Department of Oncology, Center for Cancer and Organ Diseases, Righospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, University of Copenhagen UCPH, Copenhagen, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101533916%22">Journal of thoracic disease</searchLink> [J Thorac Dis] 2026 May 31; Vol. 18 (5), pp. 559. <i>Date of Electronic Publication: </i>2026 May 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Company%22">AME Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101533916 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-1439 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220721439%22">20721439 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42306727
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/jtd-2026-1-0485
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 559
    Titles:
      – TitleFull: Are lazertinib and osimertinib comparable for treating advanced EGFR-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Urbanska EM
      – PersonEntity:
          Name:
            NameFull: Santoni-Rugiu E
      – PersonEntity:
          Name:
            NameFull: Grauslund M
      – PersonEntity:
          Name:
            NameFull: Sørensen JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 05
              Text: 2026 May 31
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2072-1439
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of thoracic disease
              Type: main
ResultId 1